Assessing the effect of Bilwadi Agada to protect the liver from alcohol damage A Clinical study

Evaluation of Hepatoprotective Activity of Bilwadi Agada in Alcoholic Liver Diseases A Clinical study - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070631

Enrollment

Registered

2024-07-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K709- Alcoholic liver disease, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient having history of Chronic alcoholism and Jaundice Serum Bilirubin in range of 2 to 3 mg/dl Patient within the age group 30 to 60years Male patients will be selected for the study

Exclusion criteria

Exclusion criteria: Patients with complications of Liver disorders – Cirrhosis of liver Systemic disorders If HBsAg positive and Hepitits A positive

Design outcomes

Primary

Measure	Time frame
A comparative study will be done on 30 samples to evaluate the effect of Bilwadi Agada and Liv 52 in alcoholic liver diseasesTimepoint: one year	—

Secondary

Measure	Time frame
the comparative effect of bilwadi agada & Liv 52 will be assessed based on CBC LFT USG parametersTimepoint: one year	—

Countries

India

Contacts

Public ContactDrAnjana L Siddapur

SANJEEVINI AYURVEDA MEDICAL COLLEGE AND HOSPITAL

anjanaraddi@gmail.com8147256942

Outcome results